|
|
 |
 |
Morning
National Palace Museum Tour (Complimentary) or Golf (At Own Cost)
|
| Thursday, April 10 |
| 11:30 |
Registration
|
| 13:00-13:30 |
Welcome and Introduction
Symposium Chair:
Hung-Chi Lue, Taiwan
Japan Kawasaki Disease Research Center:
Tomisaku Kawasaki, Japan
Immediate Past Chair:
Jane C. Burns, USA
American Heart Association:
Kathryn A. Taubert, USA |
| 13:30-14:15 |
| Hideko Ogawa Memorial Lecture |
| L01 |
Kawasaki Coronary Artery Disease: Twenty Years Outcome of Surgical Treatment (Introduced by Tomisaku Kawasaki, Japan)
Soichiro Kitamura, Japan |
|
| 14:15-15:00 |
| Epidemiology I |
| Moderators: |
Michael H. Gewitz, USA |
| |
Hiroshi Yanagawa, Japan |
| |
|
| 001 |
Epidemiologic Features of Kawasaki Disease in Taiwan, 2003-2006
Luan-Yin Chang, Taiwan |
| 002 |
Characteristics of Fatal Cases Reported as Caused by Cardiac Complications of Kawasaki Disease
Mamoru Ayusawa, Japan |
| 003 |
Kawasaki Disease in England: Ethnicity, Urbanisation and Respiratory Pathogens
Anthony Richard Harnden, USA |
|
| 15:00-15:30 |
| Epidemiology II |
| Moderators: |
Marian E. Melish, USA |
| |
Hung-Chi Lue, Taiwan |
| |
|
| 004 |
Kawasaki Disease in Multi-ethnic Singapore
Linqi Yang, Singapore |
| 005 |
Epidemiological Surveillance of Kawasaki Disease in Ontario, Canada 1995-2006
Brian McCrindle, Canada |
|
| 15:30-16:00 |
Coffee Break |
16:00-16:30 |
| State of the Art Lecture |
| Moderator: |
Mei-Hwan Wu, Taiwan |
| |
|
| L02 |
Genomic Medicine to Improve Patient Care and Safety
Yuan-Tsong Chen, Taiwan |
|
| 16:30-17:00 |
| State of the Art Lecture |
| Moderator: |
Stanford T. Shulman, USA |
| |
|
| L03 |
Genomic Studies in Kawasaki Disease
Yoshihiro Onouchi, Japan |
|
17:00-17:30 |
| State of the Art Lecture |
| Moderator: |
Yuan-Tsong Chen, Taiwan |
| |
|
| L04 |
A Genome-wide Study of Kawasaki Disease Susceptibility
David Burgner, Australia |
|
| 17:30-18:15 |
| Special Session on Global Epidemiology |
| Moderators: |
Ermias D. Belay, USA |
| |
Yosikazu Nakamura, Japan |
| |
|
| L05 |
41 years after the 1st Japan Patient
Yosikazu Nakamura, Japan |
| L06 |
32 years after the 1st Taiwan Patient
Hung-Chi Lue, Taiwan |
| L07 |
Report from North America
Ermias D. Belay, USA |
|
18:15-18:50 |
| Panel Discussion of Epidemiology Data in Some Other Asian Countries |
| Moderators: |
Ermias D. Belay, USA |
| |
Yosikazu Nakamura, Japan |
| |
|
| 043 |
China: |
Zhong-Dong Du |
| 044 |
Hong-Kong: |
Yiu-Fai Cheung |
| 045 |
India: |
Surjit Singh |
| 046 |
Indonesia: |
Najib Advani |
| 047 |
Korea: |
Joon-Sung Lee |
| 048 |
Philippines: |
Christine Bernal |
| 049 |
Thailand: |
Kritvikrom Durongpisitkul |
|
| 19:00-21:00 |
Welcome Reception (12F, Grand Ballroom) |
| Friday, April 11 |
| 8:00-8:30 |
| State of the Art Lecture |
| Moderator: |
Shiro Naoe, Japan |
| |
|
| L08 |
Pathological Characteristics of Systemic Vascular Lesions in Kawasaki Disease and Other Vasculitis Syndromes
Kei Takahashi, Japan |
|
| 8:30-9:00 |
| Etiology / Pathogenesis / Immunology I |
| Moderators: |
Susumu Furukawa, Japan |
| |
Anne H. Rowley, USA |
| |
|
| 006 |
Modulation of Activated Beta1 Integrin Expression by Prostaglandin E2 via EP Receptors in Human Coronary Arterial Endothelial Cells: Implication for Treatment of Kawasaki Disease
Madoka Kajimoto, Japan |
| 007 |
The Efficacy of Infliximab Treatment and Dynamic Changes of Inflammatory Cytokines in Patients with Refractory Kawasaki Disease
Keiichi Hirono, Japan |
|
| 9:00-9:30 |
| Etiology / Pathogenesis / Immunology II |
| Moderators: |
Tomoyoshi Sonobe, Japan |
| |
Jiunn-Ren Wu, Taiwan |
| |
|
| 008 |
Syndrome of Inappropriate Anti-Diuretic Hormone in Kawasaki Disease
Jiro Mori, Japan |
| 009 |
Analysis of Disease-associated Genes and Proteins in Kawasaki Disease
Vivek R. Nerurkar, USA |
|
| 9:30-10:00 |
| State of the Art Lecture |
| Moderators: |
Li-Min Huang, Taiwan |
| |
Jiunn-Ren Wu, Taiwan |
| |
|
| L09 |
IGA Response and the Inclusion Bodies in Acute KD
Anne H. Rowley, USA |
|
| 10:00-10:30 |
Coffee Break / Poster Session I |
| 10:30-11:15 |
| Pathogenesis / Immunology / Animal Models I |
| Moderators: |
Michael Levin, UK |
| |
Luan-Yin Chang, Taiwan |
| |
|
| 010 |
Investigation of T Cell Activation in Kawasaki Disease Patients Unresponsive to Intravenous Immunoglobulin Treatment
Hiroyuki Suzuki, Japan |
| 011 |
Increased Production of Vascular Endothelial Growth Factor-D and Lymphangiogenesis in Acute Kawasaki Disease
Ryota Ebata, Japan |
| 012 |
Multiple Genes Regulating Macrophage Activation and Responses Contribute to an Immunogenetic Phenotype Underlying Kawasaki Disease
Victoria Jane Wright, UK |
|
| 11:15-12:00 |
| Pathogenesis / Immunology /Animal Models II |
| Moderators: |
Harvey Cohen, USA |
| |
Hideshi Tomita, Japan |
| |
|
| 013 |
The Role of Interleukin-6 in the Development of Coronary Arteritis in an Animal Model of Kawasaki Disease
Howard An, Canada |
| 014 |
The Role of Innate and Adaptive Immunity in a Murine Model of Coronary Arteritis - Kawasaki Disease
Danica Schulte, USA |
| 015 |
Role of Antioxidants in Treating Immune Complex Vasculitis in Swine Model: Potential Relevance to the Early Treatment of Coronary Artery Lesion in Kawasaki Disease
Saji Philip, India |
|
| 12:15-13:50 |
| Luncheon Symposium on Immunogenetics & Immunopathogenesis of Kawasaki Disease |
| Moderators: |
Jun Abe, Japan |
| |
Bor-Luen Chiang, Taiwan |
| |
|
| L10 |
How to Understand the Genetic Background of Kawasaki Disease in the Future?
Taco W. Kuijpers, the Netherlands |
| L11 |
Functional Immunogenomics of Kawasaki Disease
Jun Abe, Japan |
| L12 |
Functional Immunogenomics of Kawasaki Disease
Jun Abe, Japan |
|
| 12:15-13:50 |
| KD Family Hours |
| Moderators: |
Tomisaku Kawasaki, Japan |
| |
Hung-Chi Lue, Taiwan |
|
| 14:00-14:45 |
| Pathology / Animal Models / Diagnosis I |
| Moderators: |
Tomoyo Matsubara, Japan |
| |
Tzou-Yien Lin, Taiwan |
| |
|
| 016 |
Implication of TLR-mediated Coronary Arteritis of Kawasaki Disease in a Mouse Model
I-Chun Lin, Taiwan |
| 017 |
Particle Size Variation Produced by Modification of Isolation of Lactobacillus Case i Cell Wall Extracts Results in Organ-specific Murine Models: Coronary Arteritis and Cholangitis
Barry Lee Myones, USA |
| 018 |
Investigating the Serial Process of the Histopathological Features on Acute Coronary Arteritis in a Rabbit Model of Kawasaki Disease
Seiichiro Ozawa, Japan |
|
| 14:45-15:30 |
| Pathology / Animal Models / Diagnosis II |
| Moderators: |
Kei Takahashi, Japan |
| |
Eeva Salo, Finland |
| |
|
| 019 |
Kawasaki Disease Patients with Redness at the Site of the Bacille Calmette-Guein Inoculation
Ritei Uehara, Japan |
| 020 |
Identification of a Novel Truncated Form of Serum Amyloid A (SAA) as a Potential Biomarker for Kawasaki Disease
John C. Whitin, USA |
| 021 |
New AHA Recommendations Improve Recognition and Treatment of Kawasaki Disease: A Multicenter Retrospective Review of Patients with Coronary Aneurysms
Elizabeth Spence Yellen, USA |
|
| 15:30-16:00 |
Coffee Break / Poster Session I |
| 16:00-16:45 |
| Yuki-Lynn Takahashi Memorial Lecture |
| |
|
| L13 |
Treatment of IVIG-Resistant Kawasaki Disease(Introduced by Masato Takahashi, USA)
Jane C. Burns, USA |
|
| 16:45-17:30 |
| Genetic Influences / Gene Expression |
| Moderators: |
Jun Abe, Japan |
| |
Yann-Jinn Lee, Taiwan |
| |
|
| 022 |
Association of Kawasaki Disease with the CTLA4 Gene
Ming-Ren Chen, Taiwan |
| 023 |
Expression of the FCGR2C Gene is Associated with Kawasaki Disease
Willemijn Breunis, Netherlands |
| 024 |
Prostaglandin E2 Suppressed, but High Dose Aspirin Augmented, CD40L Expression on the CD4+ T Cells from Patients with Kawasaki Disease
Chih-Lu Wang, Taiwan |
|
| 19:00-21:00 |
Gala Dinner (The Best 85, 85th floor, Taipei 101 Tower) |
| Saturday, April 12 |
| 8:00-8:15 |
| Invited Update |
| Moderators: |
Guo-Ying Huang, China |
| |
Kuender D. Yang, Taiwan |
| |
Ching-Tsuen Shen, Taiwan |
| |
|
| L14 |
Invited Update on IVIG Therapy
Ben Tsutomu Saji, Japan |
|
| 8:15-8:45 |
| Acute Treatment and IVIG Resistance I |
| Moderators: |
Guo-Ying Huang, China |
| |
Kuender D. Yang, Taiwan |
| |
Ching-Tsuen Shen, Taiwan |
| |
|
| 025 |
Intravenous Immunoglobulin versus Steroids for the Treatment of Kawasaki Disease in Patients with Incomplete Response to Initial Therapy
Joey A. Latino, Canada |
| 026 |
Immunoglobulin G Allotypes in Kawasaki Disease Patients with Immunoglobulin Treatment Failure
Tomoyo Matsubara, Japan |
|
| 8:45-9:30 |
| Acute Treatment and IVIG Resistance II |
| Moderators: |
Stanford T. Shulman, USA |
| |
Ming-Ren Chen, Taiwan |
| |
|
| 027 |
Stratified Selection of Primary Therapy Based on a Risk Score in Kawasaki Disease: Benefit of Intravenous Immunoglobulin and Prednisolone
Takahiro Suzuki, Japan |
| 028 |
Prediction Score of Immunoglobulin-resistant Kawasaki Disease: Validation Study for Kurume Score
Yoshihito Ogihara, Japan |
| 029 |
Analysis of the Development of Coronary Arterial Lesions in Patients Receiving Steroid Treatment in the Acute Phase of Kawasaki Disease (KD), Based on Data from the First and Second Investigations in the 19th Nationwide Survey of KD in Japan
Hiroyuki Suzuki, Japan |
|
| 9:30-10:00 |
| State of the Art Lecture |
| Moderators: |
Edward L. Kaplan, USA |
| |
|
| L15 |
Therapeutic Trials in Kawasaki Disease: Promises and Pitfalls
Jane W. Newburger, USA |
|
| 10:00-10:30 |
Coffee Break / Poster Session II |
| 10:30-11:00 |
| Cardiac Imaging / Evaluation |
| Moderators: |
Yiu-Fai Cheung, Hong-Kong |
| |
Hideaki Senzaki, Japan |
| |
|
| 030 |
Novel Multi-slice Spiral Computed Tomographic Findings Associated with Coronary Complications after Kawasaki Disease
Hiroshi Kanamaru, Japan |
| 031 |
Usefulness of MR Imaging to Evaluate Recanalized Coronary Arteries (Segmental Stenosis) due to Kawasaki Disease
Nobuyuki Katsumata, Japan |
|
| 11:00-11:45 |
| Treatment of Cardiac Complications I |
| Moderators: |
Etsuko Tsuda, Japan |
| |
Kai-Sheng Hsieh, Taiwan |
| |
|
| 032 |
Kawasaki Disease in the ICU: a Case Control Study
Mary Glode, USA |
| 033 |
Acquired Coronary Artery Fistula Complicated by Kawasaki Disease
Chi-Di Liang, Taiwan |
| 034 |
Evaluation of Down-sizing Operation for Coronary Giant Aneurysm after Kawasaki Disease
Masanori Abe, Japan |
|
| 11:45-12:30 |
| Treatment of Cardiac Complications II |
| Moderators: |
Teiji Akagi, Japan |
| |
Jou-Kou Wang, Taiwan |
| |
|
| 035 |
Impact of Warfarin versus Low-molecular-weight Heparin on Vascular Remodeling of Severe Coronary Artery Complications after Kawasaki Disease
Cedric Manlhiot, Canada |
| 036 |
Long-term Prognosis of Patients with Kawasaki Disease Complicated by Giant Coronary Aneurysms
Kenji Suda, Japan |
| 037 |
Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
Min Seob Song, Korea |
|
| 12:30-13:20 |
Lunch (Business Meeting) |
| 13:30-14:15 |
| Richard D. Rowe Memorial Lecture |
| L16 |
Intervention in Kawasaki Disease: When and How?
(Introduced by Brian W. McCrindle, Canada)
Masahiro Ishii, Japan |
|
| 14:15-14:30 |
| Invited Update |
| Moderators: |
Hirohisa Kato, Japan |
| |
Jing-Ming Wu, Taiwan |
| |
|
| L17 |
Invited Update on Treatment of Giant Coronary Aneurysm
Masato Takahashi, USA |
|
| 14:30-15:00 |
| Long-term Sequelae I |
| Moderators: |
Hirohisa Kato, Japan |
| |
Jing-Ming Wu, Taiwan |
| |
|
| 038 |
Circulating Endothelial Progenitor Cells Levels and Carotid Artery Stiffness in Kawasaki Disease
Xiao-Qin Liu, China |
| 039 |
Factors Associated with Coronary Artery Aneurysm Regression after Kawasaki Disease
Tarun Sabharwal, Canada |
|
15:00-15:45 |
| Long-term Sequelae II |
| Moderators: |
Hirotaro Ogino, Japan |
| |
Be-Tau Hwang, Taiwan |
| |
Jia-Kan Chang, Taiwan |
| |
|
| 040 |
In Vivo Plaque Composition and Morphology in Coronary Artery Lesions in Adolescents and Young Adults Long after Kawasaki Disease: New Evidence for "Atherosclerosis" from a Virtual Histology-Intravascular Ultrasound Study
Yoshihide Mitani, Japan |
| 041 |
Physical Activity in Kawasaki Disease Patients
Yahui Tammy Lin, Canada |
| 042 |
Decreased Matrix Destruction in Adult Patients with Kawasaki Disease Late after the Disease Onset
Ming-Tai Lin, Taiwan |
|
| 15:45-16:15 |
Coffee Break / Poster Session II |
16:15-16:45 |
| State of the Art Lecture |
| Moderators: |
Michael H. Gewitz, USA |
| |
|
| L18 |
Artherosclerosis, Lipid Abnormalities and Late Coronary Arterial Lesions in Kawasaki Disease
Brian W. McCrindle, Canada |
|
| 16:45-17:15 |
| Meeting Review and Commentary |
| Marian E. Melish, USA |
| Jane Newburger, USA |
|
| 17:15-17:30 |
| Farewell Remarks |
| Hung-Chi Lue, Taiwan |
| |
| Plans for the Tenth International Kawasaki Disease Symposium |
|
| 17:30 |
Adjourn |
Poster Presentation Guidelines |
 |
The size of poster is 120 cm height and 90 cm width. |
|
The poster number will be placed by the Organizer in advance. |
|
Presenters are responsible for bringing their poster to the poster room and posting it to their allocated poster board on their session in the following times: |
| |
Poster Session I |
| |
Set-up Time:
Attended Time: |
07:30 - 09:30, Friday, April 11
Coffee break hours, Friday, April 11 |
| Teardown Time: |
17:30 - 18:30, Friday, April 11 |
|
| |
|
| |
Poster Session II |
| |
Set-up Time:
Attended Time: |
07:30 - 09:30, Saturday, April 12
Coffee break hours, Saturday, April 12 |
| Teardown Time: |
17:30 - 18:30, Saturday, April 12 |
|
| |
|
|
|
